Irritation-reducing ocular ionthophoretic device

Details for Australian Patent Application No. 2005247122 (hide)

Owner Eyegate Pharma S.A.

Inventors Roy, Pierre

Agent Davies Collison Cave

Pub. Number AU-B-2005247122

PCT Pub. Number WO2005/115281

Priority 0404673 30.04.04 FR; 10/861,117 03.06.04 US

Filing date 29 April 2005

Wipo publication date 8 December 2005

Acceptance publication date 21 January 2010

International Classifications

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

A61F 9/00 (2006.01) Treatment or protection of the eyes or ears

A61N 1/30 (2006.01) Electrotherapy - Apparatus for iontophoresis or cataphoresis

A61F 2/00 (2006.01) Filters

Event Publications

14 December 2006 PCT application entered the National Phase

  PCT publication WO2005/115281 Priority application(s): WO2005/115281

19 April 2007 Change of Name(s) of Applicant(s), Section 104

  Optis France The name of the applicant has been changed to Eyegate Pharma S.A.

21 January 2010 Application Accepted

  Published as AU-B-2005247122

20 May 2010 Standard Patent Sealed

22 September 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 06 Sep 2011. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

29 September 2011 Application for Amendment

  The nature of the amendment is: Amend the invention title to read Irritation-reducing ocular iontophoretic device. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

2 February 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 06 Sep 2011

9 February 2012 Amendment Made

  The nature of the amendment is: Amend the invention title to read Irritation-reducing ocular iontophoretic device 2006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005247140-Absorbable biocompatible materials

2005247114-Use of neboglamine (CR 2249) as an antipsychotic and neuroprotective